#NEWS: Bayer today announced the U.S. FDA has accepted its new drug application (NDA) for its investigational treatment for the prevention of
secondary stroke. #TeamBayer#ScienceDelivers
Learn more: https://t.co/CmNyZQE6iK
What if American farms could help fuel the planes overhead and the trucks on the road? 🌾Bayer and @bp_plc are making it real – scaling newgold® camelina as a feedstock for renewable diesel and sustainable aviation fuel across North America.
https://t.co/1trxVr2B1G
#TeamBayer presented new late-breaking data from our Phase III OCEANIC-STROKE study today at #ESOC2026. We are committed to sharing insights that help drive impact in this area of unmet need.
Learn more: https://t.co/OZMIDP5ZS9
#News: We intend to acquire Perfuse Therapeutics, a biopharmaceutical company focused on ischemia-induced ocular diseases. Acquisition complements our pharmaceutical pipeline & reinforces our commitment to developing urgently needed therapies for patients: https://t.co/feCeNRhD8S
Each year, stroke affects millions worldwide and can lead to lasting effects, including impaired mobility and loss of speech or vision. Hear from @ChaturvediNeuro on the unmet needs in secondary stroke prevention.
#TeamBayer#StrokePrevention
We‘re proud to see our secondary stroke prevention research published in @NEJM, initially presented at the International Stroke Congress 2026. This publication reflects our continued focus on advancing science for patients at risk of secondary stroke.
https://t.co/Ia65vjrrW9
Update on Roundup Litigation: Today, a proposed U.S. nationwide class settlement was announced, designed to resolve eligible current and future RoundupTM claims through a long-term claims program. More details can be found in the link below. https://t.co/nYS4cxH9iX
Today #TeamBayer presented results from our Phase III OCEANIC-STROKE study at #ISC26. We’re excited to contribute the latest data in an area of unmet need for the stroke community.
Read more: https://t.co/ielmA3sFRf
Come see us at #ISC26! #TeamBayer will be presenting results from our Phase III OCEANIC-STROKE study during two late-breaking sessions.
We are excited to contribute to the research in stroke care.
Learn more: https://t.co/C0T82j8T2p
The U.S. Supreme Court today announced that it will review the Durnell Roundup case. The company expects a decision on the merits during the Court’s 2026 session, which ends in June.
Link to press release: https://t.co/tEu0S6L7HJ
@HERMIT37 We're genuinely sorry to hear that our advertisement didn't resonate with you. Understanding your experience is incredibly important to us, and we truly value your perspective. Please rest assured that your feedback is of great significance.
@jr3500 Hi JR. We're sorry you find the cotton so frustrating to remove. Cotton is placed in some bottles of Claritin to help minimize breakage of the product during shipment from the manufacturing plants to the store shelf. We appreciate the feedback and will share it with our team!
@MrsNicholson925 Thank you for reaching out and sharing your experience. We sincerely apologize for the frustration. Your feedback is invaluable, and we’ll escalate this to our team to drive improvements.
To assist further, please share your details via our contact form. https://t.co/kx2EEQMg1j
@tonerisms Hello. For detailed information about One A Day® ingredients, we recommend contacting our Consumer Care team directly. Here’s how you can reach them:
📞 Phone: 800-800-4793
📧 Contact Form: https://t.co/L11gPsnVMZ
As part of our commitment to support the communities we call home, Bayer is making a donation of $100,000 to support recovery efforts to @RedCross, @UnitedWaySTL and @ulstl from the devastating tornadoes that recently hit the St. Louis region.
@SmithAlischa Hi Alischa, thanks for your post. We've shared it with our internal team. Could you DM us your email for follow-up questions? By doing so, you give Bayer permission to contact you.
@SmithAlischa Alischa, thank you for your post. We have forwarded this information to our team for evaluation. In addition, may we ask you to DM us your email address in case of additional questions? If provided, you will be granting permission to Bayer to contact you for follow-up.